Cargando…
Warhead biosynthesis and the origin of structural diversity in hydroxamate metalloproteinase inhibitors
Metalloproteinase inhibitors often feature hydroxamate moieties to facilitate the chelation of metal ions in the catalytic center of target enzymes. Actinonin and matlystatins are potent metalloproteinase inhibitors that comprise rare N-hydroxy-2-pentyl-succinamic acid warheads. Here we report the...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5719088/ https://www.ncbi.nlm.nih.gov/pubmed/29213087 http://dx.doi.org/10.1038/s41467-017-01975-6 |
_version_ | 1783284432891805696 |
---|---|
author | Leipoldt, Franziska Santos-Aberturas, Javier Stegmann, Dennis P. Wolf, Felix Kulik, Andreas Lacret, Rodney Popadić, Désirée Keinhörster, Daniela Kirchner, Norbert Bekiesch, Paulina Gross, Harald Truman, Andrew W. Kaysser, Leonard |
author_facet | Leipoldt, Franziska Santos-Aberturas, Javier Stegmann, Dennis P. Wolf, Felix Kulik, Andreas Lacret, Rodney Popadić, Désirée Keinhörster, Daniela Kirchner, Norbert Bekiesch, Paulina Gross, Harald Truman, Andrew W. Kaysser, Leonard |
author_sort | Leipoldt, Franziska |
collection | PubMed |
description | Metalloproteinase inhibitors often feature hydroxamate moieties to facilitate the chelation of metal ions in the catalytic center of target enzymes. Actinonin and matlystatins are potent metalloproteinase inhibitors that comprise rare N-hydroxy-2-pentyl-succinamic acid warheads. Here we report the identification and characterization of their biosynthetic pathways. By gene cluster comparison and a combination of precursor feeding studies, heterologous pathway expression and gene deletion experiments we are able to show that the N-hydroxy-alkyl-succinamic acid warhead is generated by an unprecedented variation of the ethylmalonyl-CoA pathway. Moreover, we present evidence that the remarkable structural diversity of matlystatin congeners originates from the activity of a decarboxylase-dehydrogenase enzyme with high similarity to enzymes that form epoxyketones. We further exploit this mechanism to direct the biosynthesis of non-natural matlystatin derivatives. Our work paves the way for follow-up studies on these fascinating pathways and allows the identification of new protease inhibitors by genome mining. |
format | Online Article Text |
id | pubmed-5719088 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-57190882017-12-08 Warhead biosynthesis and the origin of structural diversity in hydroxamate metalloproteinase inhibitors Leipoldt, Franziska Santos-Aberturas, Javier Stegmann, Dennis P. Wolf, Felix Kulik, Andreas Lacret, Rodney Popadić, Désirée Keinhörster, Daniela Kirchner, Norbert Bekiesch, Paulina Gross, Harald Truman, Andrew W. Kaysser, Leonard Nat Commun Article Metalloproteinase inhibitors often feature hydroxamate moieties to facilitate the chelation of metal ions in the catalytic center of target enzymes. Actinonin and matlystatins are potent metalloproteinase inhibitors that comprise rare N-hydroxy-2-pentyl-succinamic acid warheads. Here we report the identification and characterization of their biosynthetic pathways. By gene cluster comparison and a combination of precursor feeding studies, heterologous pathway expression and gene deletion experiments we are able to show that the N-hydroxy-alkyl-succinamic acid warhead is generated by an unprecedented variation of the ethylmalonyl-CoA pathway. Moreover, we present evidence that the remarkable structural diversity of matlystatin congeners originates from the activity of a decarboxylase-dehydrogenase enzyme with high similarity to enzymes that form epoxyketones. We further exploit this mechanism to direct the biosynthesis of non-natural matlystatin derivatives. Our work paves the way for follow-up studies on these fascinating pathways and allows the identification of new protease inhibitors by genome mining. Nature Publishing Group UK 2017-12-06 /pmc/articles/PMC5719088/ /pubmed/29213087 http://dx.doi.org/10.1038/s41467-017-01975-6 Text en © The Author(s) 2017 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Leipoldt, Franziska Santos-Aberturas, Javier Stegmann, Dennis P. Wolf, Felix Kulik, Andreas Lacret, Rodney Popadić, Désirée Keinhörster, Daniela Kirchner, Norbert Bekiesch, Paulina Gross, Harald Truman, Andrew W. Kaysser, Leonard Warhead biosynthesis and the origin of structural diversity in hydroxamate metalloproteinase inhibitors |
title | Warhead biosynthesis and the origin of structural diversity in hydroxamate metalloproteinase inhibitors |
title_full | Warhead biosynthesis and the origin of structural diversity in hydroxamate metalloproteinase inhibitors |
title_fullStr | Warhead biosynthesis and the origin of structural diversity in hydroxamate metalloproteinase inhibitors |
title_full_unstemmed | Warhead biosynthesis and the origin of structural diversity in hydroxamate metalloproteinase inhibitors |
title_short | Warhead biosynthesis and the origin of structural diversity in hydroxamate metalloproteinase inhibitors |
title_sort | warhead biosynthesis and the origin of structural diversity in hydroxamate metalloproteinase inhibitors |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5719088/ https://www.ncbi.nlm.nih.gov/pubmed/29213087 http://dx.doi.org/10.1038/s41467-017-01975-6 |
work_keys_str_mv | AT leipoldtfranziska warheadbiosynthesisandtheoriginofstructuraldiversityinhydroxamatemetalloproteinaseinhibitors AT santosaberturasjavier warheadbiosynthesisandtheoriginofstructuraldiversityinhydroxamatemetalloproteinaseinhibitors AT stegmanndennisp warheadbiosynthesisandtheoriginofstructuraldiversityinhydroxamatemetalloproteinaseinhibitors AT wolffelix warheadbiosynthesisandtheoriginofstructuraldiversityinhydroxamatemetalloproteinaseinhibitors AT kulikandreas warheadbiosynthesisandtheoriginofstructuraldiversityinhydroxamatemetalloproteinaseinhibitors AT lacretrodney warheadbiosynthesisandtheoriginofstructuraldiversityinhydroxamatemetalloproteinaseinhibitors AT popadicdesiree warheadbiosynthesisandtheoriginofstructuraldiversityinhydroxamatemetalloproteinaseinhibitors AT keinhorsterdaniela warheadbiosynthesisandtheoriginofstructuraldiversityinhydroxamatemetalloproteinaseinhibitors AT kirchnernorbert warheadbiosynthesisandtheoriginofstructuraldiversityinhydroxamatemetalloproteinaseinhibitors AT bekieschpaulina warheadbiosynthesisandtheoriginofstructuraldiversityinhydroxamatemetalloproteinaseinhibitors AT grossharald warheadbiosynthesisandtheoriginofstructuraldiversityinhydroxamatemetalloproteinaseinhibitors AT trumanandreww warheadbiosynthesisandtheoriginofstructuraldiversityinhydroxamatemetalloproteinaseinhibitors AT kaysserleonard warheadbiosynthesisandtheoriginofstructuraldiversityinhydroxamatemetalloproteinaseinhibitors |